Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05488431
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:48.241772+00:00
Published At
2025-12-17T00:00:00+00:00
Record Updated At
2025-12-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Dyslipidemias", "Cardiovascular Diseases", "HIV Infections", "Atherosclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-17"
protocolSection.identificationModule.nctId
"NCT05488431"
protocolSection.identificationModule.officialTitle
"Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Dyslipidemias (protocolSection.conditionsModule.conditions)
  • Cardiovascular Diseases (protocolSection.conditionsModule.conditions)
  • HIV Infections (protocolSection.conditionsModule.conditions)
  • Atherosclerosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.